Loading...
In September 1928, Alexander Fleming returned from vacation to his cluttered laboratory at St. Mary's Hospital in London. He found a petri dish of Staphylococcus bacteria left uncovered near an open window. A blue-green mold — Penicillium notatum — had drifted in and contaminated the plate. Instead of discarding it, Fleming noticed something remarkable: the bacteria surrounding the mold had dissolved. The mold was producing a substance that killed bacteria — a chemical weapon it had evolved over millions of years to fight rival microbes in the soil. Fleming published his findings in 1929, naming the substance 'penicillin.' But he couldn't purify or concentrate it. The compound was unstable, difficult to extract, and Fleming lacked the chemistry expertise to solve these problems. For a f...
Popular framing: Fleming got lucky with a contaminated petri dish.
Structural analysis: A defense weapon evolved in soil microbes was exapted — repurposed — first into a laboratory curiosity by Fleming, then into a usable drug only after Florey and Chain solved the purification chemistry, then into a mass therapy only after WWII supplied the activation energy (capital, fermentation infrastructure, urgent demand). Each transition required a different stack; the chance event was real but unusable without ten more years of catalysts.
The popular framing erases the decade-long failure between observation and application, making scientific breakthroughs seem faster and more individual than they are. This matters because it misdirects innovation policy toward funding 'lone genius' discovery moments rather than the translation infrastructure — funding, teams, engineering capacity — that actually converts observations into outcomes. It also blinds us to the antifragile nature of Penicillium's chemistry: the same evolutionary arms race that produced our medicine is now producing our resistance crisis.
